AOD‐9604 is a synthetic 15‐amino acid peptide fragment derived from the C‐terminal region of human growth hormone (amino acids 176‐191). Originally developed as an anti obesity compound, it has become a widely used research tool for studying fat metabolism, lipolysis, and more recently cartilage repair, valued particularly for its ability to mimic the fat‐metabolizing activity of growth hormone without the broader hormonal side effects that come with it.

What makes AOD‐9604 particularly interesting as a research compound is the separation it achieves between the fat‐metabolizing and growth‐promoting functions of growth hormone. It does not activate the hGH receptor or raise IGF‐1 levels, and it has no meaningful effect on blood glucose or insulin sensitivity. Its effects stay focused on adipose tissue:

• AOD‐9604 stimulates lipolysis primarily through beta‐3 adrenergic receptor pathways in adipose tissue, driving the breakdown of stored triglycerides into free fatty acids. Studies confirmed that animals lacking these receptors showed no lipolytic response, validating this as the primary pathway.

• Alongside breaking down existing fat, AOD‐9604 also suppresses fatty acid synthesis, limiting new fat formation. This dual action has been demonstrated consistently in obese rodent models.

• Preclinical data suggests AOD‐9604 shifts the metabolic balance toward burning fatty acids for energy rather than storing them, with effects observed particularly in visceral adipose tissue.

• More recent work has identified a second research area. AOD‐9604 appears to stimulate proteoglycan and collagen synthesis in chondrocytes through growth factor signaling pathways distinct from its lipolytic mechanism, supporting cartilage matrix repair in joint models.

Integrated Research Applications

AOD‐9604 started as a fat metabolism compound but has since opened up a second research direction in joint and cartilage biology:

• The bulk of AOD‐9604 research sits here. In ob/ob mice and Zucker rat models, it has consistently reduced fat mass, decreased epididymal and brown adipose tissue weight, and improved lipid profiles without affecting lean tissue or glucose homeostasis. The regional selectivity toward visceral fat has drawn particular interest given its relevance to metabolic disease research.

• Beyond simply breaking fat down, AOD‐9604 has been studied for its ability to limit new fat cell formation, making it useful for researchers investigating both sides of the fat accumulation equation in cell and animal models.

• Cartilage and joint repair models: Intra‐articular injection of AOD‐9604 in a collagenase induced rabbit osteoarthritis model showed improved cartilage architecture and regeneration. Studies have also reported stimulation of proteoglycan and collagen synthesis in chondrocyte preparations, pointing to a meaningful role in joint research independent of its metabolic activity.

• Bone and musculoskeletal research: Some work has extended into bone repair and osteoporosis models, where AOD‐9604 has shown early signs of supporting bone remodeling, though this area is less developed than its fat metabolism and cartilage research.

Analytical Validation, Formulation, and Storage

Research grade AOD‐9604 is supplied as a lyophilized white powder in glass vials at ≥99% purity, verified by HPLC with a batch‐specific certificate of analysis included.

Formulation: Lyophilized powder for reconstitution with an appropriate aqueous solvent, supplied without dosing instructions of any kind.

Storage follows standard peptide handling practice:

• Store lyophilized vials at or below −20 °C in a cool, dark, dry environment.

• After reconstitution, refrigerate at 2–8 °C, avoid repeated freeze‐thaw cycles, and use within laboratory‐defined timeframes.

NextGenPeps supplies AOD‐9604 as a high purity research peptide intended strictly for controlled laboratory use in vitro or in established animal models, such as murine systems. This compound is not approved as a drug, diagnostic, or dietary ingredient, and is not manufactured, packaged, or marketed for consumption, self experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.